Extract
We have read with great interest and welcome the publication of a prospective multicentre study regarding the role of mediastinal staging by video-assisted mediastinoscopy (VAM) in patients with clinical N1 (cN1) nonsmall cell lung cancer (NSCLC) [1]. The objective of the study was to assess the sensitivity, negative predictive value and accuracy of VAM in a well-defined group of patients with cN1.
Abstract
Video-assisted mediastinoscopy or VAM-lymphadenectomy is not a standard procedure in cN1 disease http://ow.ly/dAZq30irs63
Footnotes
Conflict of interest: None declared.
- Received January 15, 2018.
- Accepted January 23, 2018.
- Copyright ©ERS 2018
INDIVIDUALS
Log in using your username and password
LIBRARY USERS
Log in through your institution
If your library has a subscription, you may already be logged in via your IP address. Otherwise you may be able to log in via one of the following routes.
You may be able to gain access using your login credentials for your institution. Contact your library if you do not have a username and password.
If your organization uses OpenAthens, you can log in using your OpenAthens username and password. To check if your institution is supported, please see this list. Contact your library for more details.
If you think you should have access, please contact your librarian or email journals@ersnet.org
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
CONTACT US
If you have any questions about the ERS publications website, please contact journals@ersnet.org
Vol 51 Issue 4
Table of Contents
Adding an invasive procedure will not necessarily change treatment or outcome of NSCLC patients with preoperative clinical N1 disease
